Researchers Raise Concerns about Faster Aging, Possible Early-Onset Dementia, for Children and Young Adult Cancer Survivors

Cancer Survivors Age Faster: A New Understanding of Long-Term Effects A groundbreaking new study from the University of Rochester’s Wilmot Cancer Institute and St. Jude Children’s Research Hospital confirms what many cancer survivors have long suspected: surviving cancer, particularly in youth, can accelerate the aging process. This isn’t just about feeling older; researchers are observing … Read more

Saskatchewan lowers age eligibility for breast cancer screenings

Saskatchewan’s Breast Cancer Screening Shift: A Sign of Things to Come? Saskatchewan’s recent decision to lower the age for routine breast cancer screening to 40 by June – following an initial drop to 43 – isn’t happening in a vacuum. It’s part of a growing national and international conversation about the optimal age to begin … Read more

Scots Strictly Come Dancing star reveals breast cancer battle

Dr. Punam Krishan’s Diagnosis: A Turning Point in Cancer Awareness and Early Detection The recent revelation by Dr. Punam Krishan, beloved TV presenter and Strictly Come Dancing star, about her breast cancer diagnosis has resonated deeply with the public. Beyond the outpouring of support for the doctor herself, her story highlights a crucial shift in … Read more

A new mom battling postpartum depression skipped a routine appointment. An unrelated visit led to an unexpected diagnosis.

The Silent Epidemic: Why Prioritizing Preventative Care is More Critical Than Ever Ameilia Boodoosingh Gopie’s story, a harrowing journey through Stage III breast cancer discovered after neglecting routine check-ups, isn’t unique. It’s a stark reminder of a growing trend: the postponement of preventative healthcare, often with devastating consequences. While life understandably gets in the way … Read more

Combination therapy offers hope for AML patients facing drug resistance

AML Treatment Breakthrough: Could Breast Cancer Drugs Hold the Key? Acute myeloid leukemia (AML), a rapidly progressing cancer of the blood and bone marrow, affects over 20,000 Americans annually. While the introduction of venetoclax in 2019, combined with azacitidine, offered a significant step forward in treatment, the development of drug resistance remains a major hurdle. … Read more

New Gel Offers Tool for Breast Cancer Research & Insights into Tumor Development

Share this Article Beyond Matrigel: The Future of 3D Cell Culture and Cancer Research For decades, researchers studying breast cancer – and many other cancers – have relied heavily on a complex gel called Matrigel. Derived from mouse tumors, it mimics the basement membrane, the natural environment surrounding cells in the body. But as a … Read more

Study reveals a therapeutic vulnerability in aggressive subtype of triple-negative breast cancer

Targeting a Weakness in Aggressive Breast Cancer: A New Hope for Rb1-Deficient Tumors A groundbreaking study published in Science Translational Medicine is reshaping the landscape of treatment for a particularly aggressive form of triple-negative breast cancer. Researchers at The University of Texas MD Anderson Cancer Center have identified a critical vulnerability in tumors lacking the … Read more

New tech could cut false positives in breast cancer screening

Beyond the Biopsy: How New Ultrasound Tech is Revolutionizing Breast Cancer Detection For decades, the mammogram has been the cornerstone of breast cancer screening. But for women with dense breast tissue – a surprisingly common condition affecting up to half of all women – mammograms can be less effective, leading to more false positives and … Read more

How diabetes medications may influence cancer risk and progression

Diabetes Drugs as Cancer Fighters: A New Frontier in Personalized Medicine For years, the link between Type 2 Diabetes (T2DM) and increased cancer risk has been recognized. But recent research is shifting the focus from simply managing blood sugar to understanding how anti-diabetic medications themselves might impact cancer development and progression. A groundbreaking review published … Read more

Day & night: Cancer disrupts the brain’s natural rhythm

Why Chronobiology Is the Next Frontier in Cancer Therapy For decades scientists have known that cancer can flatten the natural day‑night rhythm of stress hormones like cortisol (corticosterone in rodents). New research from Jeremy Borniger’s lab at Cold Spring Harbor Laboratory shows that this disruption isn’t a side‑effect – it’s an early driver of tumor … Read more